Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Nektar Therapeutics
Scientific Title
A Phase 2, Randomized, Non-Comparative, Open-Label Study of NKTR-214 in Combination With Nivolumab and of Chemotherapy in Cisplatin Ineligible, Locally Advanced or Metastatic Urothelial Cancer Patients With Low PD-L1 Expression